An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2021-03-19
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 25800
- Registration Number
- NCT04641481
- Locations
- 🇮🇳
Pt BD SHARMA,PGIMS/UHS, Rohtak, Haryana, India
Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 60
- Registration Number
- NCT04603131
- Locations
- 🇮🇳
Medanta - The Medicity, Gurgaon, Haryana, India
🇮🇳Panchsheel Hospital, Delhi, India
🇮🇳King George Hospital, Visakhapatnam, Andhra Pradesh, India
Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 360
- Registration Number
- NCT04596696
- Locations
- 🇻🇳
Vietnam Military Medical University Hospital, Hanoi, Vietnam
Safety and Immunogenicity of BBV121
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 48
- Registration Number
- NCT04478656
- Locations
- 🇮🇳
Bharat Biotech International Ltd, Hyderabad, Telangana, India
Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 755
- Registration Number
- NCT04471519
- Locations
- 🇮🇳
All India Institute of Medical Sciences, Delhi, New Delhi, India
🇮🇳Rana Hospital and Trauma Center, Gorakhpur, Uttar Pradesh, India
🇮🇳Jeevan Rekha Hospital, Belgaum, Karnataka, India
A Trial Using Double-Bolus THR-100 Versus Streptokinase
- First Posted Date
- 2011-02-28
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 120
- Registration Number
- NCT01305226
- Locations
- 🇮🇳
Narayana Hrudayalaya, Bangalore, Karnataka, India
🇮🇳Sri Jayadeva Institute of Cardiology., Bangalore, Karnataka, India
🇮🇳Institute of Post Graduate Medical Education and Research (IPGMER), Kolkata, West Bengal, India
A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E
- Conditions
- Interventions
- First Posted Date
- 2011-02-28
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 6800
- Registration Number
- NCT01305109
- Locations
- 🇮🇳
Centre for Health Research and Development, Society for Applied Studies, New Delhi, India
🇮🇳Christian Medical College, Vellore, India
🇮🇳Shirdi Sai Baba Rural Hospital, KEM Hospital Research Centre,Vadu Rural Health, Pune, Maharashtra, India
Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old
- Conditions
- Interventions
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 540
- Registration Number
- NCT00439660
- Locations
- 🇮🇳
Society for Applied Studies (SAS), New Delhi, India